De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety

BACKGROUND: Antifungal treatment is common in critically ill patients, but only a small proportion of patients receiving antifungals have a proven fungal infection. However, antifungal treatment has side effects such as toxicity, emergence of resistance, and high cost. Moreover, empirical antifungal...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaffal, Karim, Poissy, Julien, Rouze, Anahita, Preau, Sébastien, Sendid, Boualem, Cornu, Marjorie, Nseir, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908771/
https://www.ncbi.nlm.nih.gov/pubmed/29675561
http://dx.doi.org/10.1186/s13613-018-0392-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908771/
https://www.ncbi.nlm.nih.gov/pubmed/29675561
http://dx.doi.org/10.1186/s13613-018-0392-8

Ejemplares similares